| Expression pattern: |
UP |
| Associated gene: |
MMP2, AGO2 |
| Associated microRNA: |
miR-185-5p |
| Biological function: |
promoted ECM catabolism and suppressed ECM anabolism in NP cells, contributing to IDD progression |
| Molecular mechanism: |
Acts as a competitive endogenous RNA (ceRNA) by sponging miR-185-5p to upregulate MMP2, driving ECM degradation |
| Biological pathway or process: |
ceRNA regulation (promotes); other pathway/process (promotes) |
| Detected method: |
Q
H
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; RT-qPCR; FISH / smFISH; RIP (RNA Immunoprecipitation); RNA Pull-Down; Luciferase Reporter Assay; Transfection; Western Blot; Northern Blot; Clinical Sample Validation |
| Clinical significance: |
Higher circ-TIMP2 expression in IDD NP tissues and positively correlated with IDD grade |
| Description: |
circ-TIMP2 is up-regulated in degenerative NP tissues and correlates with IDD grade. It acts in the cytoplasm as a ceRNA by sponging miR-185-5p, thereby relieving repression of MMP2 and promoting ECM catabolism while suppressing ECM anabolism in NP cells. |
| Confidence score: |
0.8006 |